BIOGF
Price:
$0.66
Market Cap:
$27.24M
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-10-14
Stock Exchange
OTC
Ticker
BIOGF
According to Biocartis Group N.V.’s latest financial reports and current stock price. The company's current ROE is 203.74%. This represents a change of 146.37% compared to the average of 82.70% of the last 4 quarters.
The mean historical ROE of Biocartis Group N.V. over the last ten years is -14.93%. The current 203.74% ROE has changed -1464.69% with respect to the historical average. Over the past ten years (40 quarters), BIOGF's ROE was at its highest in in the June 2021 quarter at 15.74%. The ROE was at its lowest in in the December 2020 quarter at -85.45%.
Average
-14.93%
Median
-48.17%
Minimum
-170.90%
Maximum
215.89%
Discovering the peaks and valleys of Biocartis Group N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 125.35%
Maximum Annual ROE = 215.89%
Minimum Annual Increase = -223.37%
Minimum Annual ROE = -170.90%
| Year | ROE | Change |
|---|---|---|
| 2022 | 215.89% | 2.39% |
| 2021 | 210.85% | -223.37% |
| 2020 | -170.90% | 125.35% |
| 2019 | -75.84% | 37.57% |
| 2018 | -55.13% | 73.73% |
| 2017 | -31.73% | -38.24% |
| 2016 | -51.38% | 48.35% |
| 2015 | -34.63% | -22.97% |
| 2014 | -44.96% | -59.67% |
| 2013 | -111.47% | -7.68% |
The current ROE of Biocartis Group N.V. (BIOGF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
85.28%
5-year avg
24.97%
10-year avg
-14.93%
Biocartis Group N.V.’s ROE is greater than Taihe Group, Inc. (0.81%), greater than Kiaro Holdings Corp. (-146.87%), less than Elegance Optical International Holdings Limited (0%), greater than SymBio Pharmaceuticals Limited (-123.34%), less than RetinalGenix Technologies Inc. (146.75%), greater than Goodness Growth Holdings, Inc. (-46.28%), less than MCI Onehealth Technologies Inc. (0%), greater than Karolinska Development AB (publ) (-11.56%), greater than Herantis Pharma Oyj (-724.30%), less than Oncopeptides AB (publ) (9.01%),
| Company | ROE | Market cap |
|---|---|---|
| 0.81% | $71.85M | |
| -146.87% | $442.00 | |
| 0% | $63.38M | |
| -123.34% | $30.49M | |
| 146.75% | $59.54M | |
| -46.28% | $61.05M | |
| 0% | $54.04M | |
| -11.56% | $68.85M | |
| -724.30% | $59.47M | |
| 9.01% | $55.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biocartis Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biocartis Group N.V.'s ROE?
How is the ROE calculated for Biocartis Group N.V. (BIOGF)?
What is the highest ROE for Biocartis Group N.V. (BIOGF)?
What is the 3-year average ROE for Biocartis Group N.V. (BIOGF)?
What is the 5-year average ROE for Biocartis Group N.V. (BIOGF)?
How does the current ROE for Biocartis Group N.V. (BIOGF) compare to its historical average?